Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Grafting”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01117077
What this trial is testing

The Immune Tolerance Mechanism Induced by IL-17-producing Regulatory T Cells in the Orthotopic Liver Transplant Recipients With Aspergillosis

Who this might be right for
Liver TransplantationAspergillusInterleukin-17+2 more
Shanghai Jiao Tong University School of Medicine 50
Not applicableStudy completedNCT07570901
What this trial is testing

Impact of Delta Model of End Stage Liver Disease (MELD) in High MELD Liver Transplant Recipients

Who this might be right for
Liver Disease (Alcoholic or Not)Liver Transplantation
University of Jena 446
Early research (Phase 1)Study completedNCT02204930
What this trial is testing

PeproStat Haemostat Study in Subjects Undergoing Liver Surgery

Who this might be right for
Hemorrhage
Haemostatix Ltd 20
Testing effectiveness (Phase 2)UnknownNCT01034345
What this trial is testing

Effect of Rapamycin on Tolerance-related Biomarkers on Stable Liver Transplant Recipients

Who this might be right for
Liver Transplantation
Hospital Clinic of Barcelona 52
Not applicableStudy completedNCT01922557
What this trial is testing

Thoracic Fluid Content and Acute Lung Injury

Who this might be right for
Acute Lung Injury
National Taiwan University Hospital 22
Not applicableStudy completedNCT05669677
What this trial is testing

Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease

Who this might be right for
Chronic or Recovered Hepatitis BChronic or Recovered Hepatitis CChronic or Recovered Hepatitis D+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 233
Not applicableUnknownNCT04762550
What this trial is testing

Thrombin Generation in Liver Transplant Surgery

Who this might be right for
Liver TransplantationThrombinHemostasis, Surgical+2 more
University Health Network, Toronto 100
Not applicableStudy completedNCT03386435
What this trial is testing

The Effect of Remote Ischemic Preconditioning in Living Donor Hepatectomy

Who this might be right for
Tissue DonorsLiver TransplantationIschemia Reperfusion Injury
Asan Medical Center 160
Large-scale testing (Phase 3)Study completedNCT00355862
What this trial is testing

Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of Regensburg 525
Not applicableActive Not RecruitingNCT05981196
What this trial is testing

Disparities Among Liver Transplant Patients

Who this might be right for
End Stage Liver DIsease
Mayo Clinic 100
Post-approval studies (Phase 4)Study completedNCT02059460
What this trial is testing

Perioperative Evaluation of Terlipressin Infusion During Living Donor Liver Transplantation on Incidence of Acute Kidney

Who this might be right for
Acute Kidney InjuryLiver TransplantationTerlipressin+1 more
National Liver Institute, Egypt 25
Not applicableStudy completedNCT02124382
What this trial is testing

Living Donor Liver Transplantation in Children

Who this might be right for
Pediatric Liver Transplanted RecipientsHealthy Donors
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 500
Not applicableLooking for participantsNCT07695363
What this trial is testing

Restrictive Fluid Management In Liver Transplantation (REFIL)

Who this might be right for
Liver Transplantation (LT)End-stage Liver Disease (ESLD)
Centre hospitalier de l'Université de Montréal (CHUM) 866
Post-approval studies (Phase 4)Study completedNCT03781726
What this trial is testing

Multi-center Study to Transplant Hepatitis-C Infected Kidneys

Who this might be right for
Renal Failure ChronicHepatitis C
Raymond Chung 30
Testing effectiveness (Phase 2)Study completedNCT02849015
What this trial is testing

Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver

Who this might be right for
Liver TumorEvidence of Liver Transplantation
Fuda Cancer Hospital, Guangzhou 20
Large-scale testing (Phase 3)WithdrawnNCT01884038
What this trial is testing

Safety and Efficacy of Perioperative Remodulin® in Orthotopic Liver Transplant Recipients

Who this might be right for
Liver Transplant
United Therapeutics
Testing effectiveness (Phase 2)UnknownNCT04035876
What this trial is testing

Combination Camrelizumab (SHR-1210) and Apatinib for Downstaging/Bridging of HCC Before Liver Transplant

Who this might be right for
Hepatocellular CarcinomaLiver Transplant
Zhejiang University 120
Early research (Phase 1)Looking for participantsNCT06327308
What this trial is testing

Evaluation of Cirrhotic Cardiomyopathy by Cardiac MRI in Patients Waiting for Liver Transplant.

Who this might be right for
CirrhosisRegistered on Transplant List
Centre Hospitalier Universitaire de Besancon 60
Testing effectiveness (Phase 2)Study completedNCT01128335
What this trial is testing

Efficacy, Safety, Tolerability, Pharmacokinetics of Sotrastaurin-tacrolimus vs. Mycophenolic Acid-tacrolimus in de Novo Liver Transplant Patients

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 200
Testing effectiveness (Phase 2)Study completedNCT03395574
What this trial is testing

Effect of Terlipressin on Cerebral Oxygen Saturation During Liver Transplantation

Who this might be right for
Terlipressin Adverse ReactionLiver Transplantation
Kasr El Aini Hospital 30
Next Page